31.10.2017 - 02.11.2017De Vere Grand Connaught Rooms, 61 - 65 Great Queen Street, WC2B 5DA London, Großbritannien
Time: 1:00 pm to 4:30 pm
Kongressthemen Gene Therapy for Rare Disorders Europe is devoted to overcoming these challenges, focusing specifically on the clinical, manufacturing, regulatory and reimbursement hurdles that need to be overcome for gene therapies to reach their full potential.
Uniting leaders from Pfizer, GSK, Shire and uniQure, this meeting focusses specifically on delivering practical insights into developing the next generation of gene therapies that promise improved efficacy, enhanced safety and commercial viability.
